MMP9 and pituitary gland adenoma: Recent evidence indicates that CD44, CD34, PTTG, FGFR4, MMP9, E‐Cadherin, and N‐Cadherin serve as biomarkers of aggressive pituitary adenomas (Mete et al., 2012; Valea et al., 2022).